| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | DOCK1 MIA3 RIPOR2 CCDC42 SCG2 E2F7 ID1 MACF1 ERVK-19 KDR ACTN1 FLOT1 KIF20B CCDC136 EPAS1 | 6.48e-05 | 1483 | 67 | 15 | GO:0048646 |
| GeneOntologyBiologicalProcess | cilium assembly | 9.29e-05 | 444 | 67 | 8 | GO:0060271 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 1.04e-04 | 870 | 67 | 11 | GO:0030855 | |
| GeneOntologyBiologicalProcess | microtubule-based process | RIPOR2 CCDC42 IFT74 CNTRL SYNE2 MACF1 KIF3C APP SGO1 CFAP53 HYDIN KIF20B | 1.37e-04 | 1058 | 67 | 12 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium organization | 1.50e-04 | 476 | 67 | 8 | GO:0044782 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.69e-04 | 85 | 67 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.69e-04 | 85 | 67 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 1.78e-04 | 161 | 67 | 5 | GO:0046328 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.02e-04 | 89 | 67 | 4 | GO:0006949 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 2.39e-04 | 269 | 67 | 6 | GO:0002064 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 2.59e-04 | 95 | 67 | 4 | GO:0002090 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 2.85e-04 | 278 | 67 | 6 | GO:0031503 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell apoptotic process | 2.97e-04 | 40 | 67 | 3 | GO:2000352 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 3.03e-04 | 670 | 67 | 9 | GO:0120031 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.04e-04 | 99 | 67 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.15e-04 | 100 | 67 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 3.57e-04 | 685 | 67 | 9 | GO:0030031 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DOCK1 RIPOR2 SIPA1L1 SYNE2 ID1 MACF1 KDR CGNL1 FNBP1L APP FLOT1 BBS10 | 4.01e-04 | 1189 | 67 | 12 | GO:0044087 |
| GeneOntologyBiologicalProcess | JNK cascade | 4.62e-04 | 198 | 67 | 5 | GO:0007254 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 4.96e-04 | 432 | 67 | 7 | GO:0010631 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 4.99e-04 | 309 | 67 | 6 | GO:1901888 | |
| GeneOntologyBiologicalProcess | epithelium migration | 5.17e-04 | 435 | 67 | 7 | GO:0090132 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 5.36e-04 | 115 | 67 | 4 | GO:0150115 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 5.46e-04 | 577 | 67 | 8 | GO:0001667 | |
| GeneOntologyBiologicalProcess | tissue migration | 5.61e-04 | 441 | 67 | 7 | GO:0090130 | |
| GeneOntologyBiologicalProcess | actin filament-based transport | 5.61e-04 | 11 | 67 | 2 | GO:0099515 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 7.34e-04 | 125 | 67 | 4 | GO:0016579 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.32e-05 | 263 | 68 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | centrosome | CCDC42 MTUS1 IFT74 CEP112 CNTRL CIR1 ID1 SGO1 FLOT1 CFAP53 KIF20B | 3.56e-05 | 770 | 68 | 11 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | CCDC42 MTUS1 IFT74 CEP112 CNTRL CIR1 ID1 SGO1 FLOT1 CFAP53 KIF20B | 1.72e-04 | 919 | 68 | 11 | GO:0005815 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT2 KRT6B LMNB1 KRT6C MTUS1 MACF1 KIF3C ACTN1 CFAP53 KIF20B | 6.22e-04 | 899 | 68 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | dense core granule | 8.07e-04 | 56 | 68 | 3 | GO:0031045 | |
| GeneOntologyCellularComponent | intermediate filament | 8.64e-04 | 227 | 68 | 5 | GO:0005882 | |
| Domain | Intermediate_filament_CS | 6.03e-05 | 63 | 63 | 4 | IPR018039 | |
| Domain | Actinin_actin-bd_CS | 6.17e-05 | 23 | 63 | 3 | IPR001589 | |
| Domain | Spectrin | 6.17e-05 | 23 | 63 | 3 | PF00435 | |
| Domain | ACTININ_2 | 6.17e-05 | 23 | 63 | 3 | PS00020 | |
| Domain | ACTININ_1 | 6.17e-05 | 23 | 63 | 3 | PS00019 | |
| Domain | Keratin_2_head | 7.04e-05 | 24 | 63 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 7.04e-05 | 24 | 63 | 3 | PF16208 | |
| Domain | Keratin_II | 9.00e-05 | 26 | 63 | 3 | IPR003054 | |
| Domain | Filament | 9.64e-05 | 71 | 63 | 4 | SM01391 | |
| Domain | IF | 1.02e-04 | 72 | 63 | 4 | PS00226 | |
| Domain | Filament | 1.07e-04 | 73 | 63 | 4 | PF00038 | |
| Domain | Spectrin_repeat | 1.26e-04 | 29 | 63 | 3 | IPR002017 | |
| Domain | IF | 1.26e-04 | 76 | 63 | 4 | IPR001664 | |
| Domain | Spectrin/alpha-actinin | 1.69e-04 | 32 | 63 | 3 | IPR018159 | |
| Domain | SPEC | 1.69e-04 | 32 | 63 | 3 | SM00150 | |
| Domain | CH | 1.38e-03 | 65 | 63 | 3 | SM00033 | |
| Domain | CH | 1.70e-03 | 70 | 63 | 3 | PF00307 | |
| Domain | - | 1.78e-03 | 71 | 63 | 3 | 1.10.418.10 | |
| Domain | CH | 1.92e-03 | 73 | 63 | 3 | PS50021 | |
| Domain | CH-domain | 2.08e-03 | 75 | 63 | 3 | IPR001715 | |
| Domain | SH3 | 6.08e-03 | 216 | 63 | 4 | PS50002 | |
| Domain | SH3_domain | 6.49e-03 | 220 | 63 | 4 | IPR001452 | |
| Domain | Kinesin_motor_CS | 8.44e-03 | 41 | 63 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 9.25e-03 | 43 | 63 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 9.67e-03 | 44 | 63 | 2 | PS00411 | |
| Domain | - | 9.67e-03 | 44 | 63 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 9.67e-03 | 44 | 63 | 2 | IPR001752 | |
| Domain | Kinesin | 9.67e-03 | 44 | 63 | 2 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 9.67e-03 | 44 | 63 | 2 | PS50067 | |
| Domain | KISc | 9.67e-03 | 44 | 63 | 2 | SM00129 | |
| Pubmed | DOCK1 HIPK3 KMT2C RIPOR2 CNTRL MACF1 ACTN1 CGNL1 COPS5 EPAS1 | 4.21e-08 | 486 | 69 | 10 | 20936779 | |
| Pubmed | KRT2 KRT6B LMNB1 KRT6C CEP112 DTNA CNTRL SYNE2 MARF1 MACF1 KDR ACTN1 FNBP1L SGO1 MINDY2 | 1.18e-07 | 1442 | 69 | 15 | 35575683 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.44e-06 | 588 | 69 | 9 | 38580884 | |
| Pubmed | 3.60e-06 | 322 | 69 | 7 | 26514267 | ||
| Pubmed | Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival. | 3.88e-06 | 2 | 69 | 2 | 21984395 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25855980 | ||
| Pubmed | KMT2C TAOK3 MIA3 RIPOR2 CEP112 SIPA1L1 CNTRL TTC14 MACF1 SDF4 GOLM1 | 8.94e-06 | 1084 | 69 | 11 | 11544199 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 27075652 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 29357356 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20824203 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 34124066 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7543104 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 10813585 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 16480949 | ||
| Pubmed | LGI3 interacts with flotillin-1 to mediate APP trafficking and exosome formation. | 1.16e-05 | 3 | 69 | 2 | 20461023 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24465508 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 12464608 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 19818105 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 19837976 | ||
| Pubmed | A conserved two-step binding for the UAF1 regulator to the USP12 deubiquitinating enzyme. | 2.32e-05 | 4 | 69 | 2 | 27650958 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 26476925 | ||
| Pubmed | Hypoxic-ischemic gene expression profile in the isolated variant of biliary atresia. | 2.32e-05 | 4 | 69 | 2 | 26510548 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 39432777 | ||
| Pubmed | HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein. | 2.32e-05 | 4 | 69 | 2 | 24312169 | |
| Pubmed | Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease. | 2.32e-05 | 4 | 69 | 2 | 35269588 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 33844468 | ||
| Pubmed | Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. | 2.32e-05 | 4 | 69 | 2 | 21068842 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 19021062 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 24850727 | ||
| Pubmed | Kidney development and gene expression in the HIF2alpha knockout mouse. | 2.32e-05 | 4 | 69 | 2 | 17342756 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 30466959 | ||
| Pubmed | 2.35e-05 | 430 | 69 | 7 | 32581705 | ||
| Pubmed | Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. | 3.86e-05 | 5 | 69 | 2 | 15451666 | |
| Pubmed | UAF1 is a subunit of multiple deubiquitinating enzyme complexes. | 3.86e-05 | 5 | 69 | 2 | 19075014 | |
| Pubmed | WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme complex. | 3.86e-05 | 5 | 69 | 2 | 20147737 | |
| Pubmed | CCDC38 is required for sperm flagellum biogenesis and male fertility in mice. | 3.86e-05 | 5 | 69 | 2 | 35587122 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 20301457 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 23926111 | ||
| Pubmed | 4.01e-05 | 191 | 69 | 5 | 33762435 | ||
| Pubmed | 4.05e-05 | 1049 | 69 | 10 | 27880917 | ||
| Pubmed | 4.64e-05 | 197 | 69 | 5 | 23686814 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 4.64e-05 | 197 | 69 | 5 | 20811636 | |
| Pubmed | KRT2 MIA3 LAMTOR2 CEP112 SYNE2 CIR1 MACF1 SDF4 GOLM1 APP FLOT1 | 4.66e-05 | 1297 | 69 | 11 | 33545068 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.68e-05 | 853 | 69 | 9 | 28718761 | |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 9113979 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 9.80e-05 | 120 | 69 | 4 | 31413325 | |
| Pubmed | The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair. | 1.08e-04 | 8 | 69 | 2 | 27463890 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 18443354 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 20886612 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.23e-04 | 560 | 69 | 7 | 21653829 | |
| Pubmed | Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46. | 1.38e-04 | 9 | 69 | 2 | 21183687 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 12053176 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 10395786 | ||
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 1.73e-04 | 10 | 69 | 2 | 28533284 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 24145035 | ||
| Pubmed | Identification of differential protein interactors of lamin A and progerin. | 1.82e-04 | 55 | 69 | 3 | 21327095 | |
| Pubmed | 2.03e-04 | 57 | 69 | 3 | 31862882 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 32853985 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 24355925 | ||
| Pubmed | 2.24e-04 | 59 | 69 | 3 | 26371508 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 28595999 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 22919064 | ||
| Pubmed | Sostdc1 defines the size and number of skin appendage placodes. | 2.53e-04 | 12 | 69 | 2 | 22509524 | |
| Pubmed | iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications. | 2.53e-04 | 12 | 69 | 2 | 31118412 | |
| Pubmed | 2.73e-04 | 63 | 69 | 3 | 16831889 | ||
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 3.10e-04 | 162 | 69 | 4 | 16502470 | |
| Pubmed | 3.41e-04 | 68 | 69 | 3 | 22779921 | ||
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 19874786 | ||
| Pubmed | Mechanical regulation of glycolysis via cytoskeleton architecture. | 3.48e-04 | 14 | 69 | 2 | 32051585 | |
| Pubmed | SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis. | 4.01e-04 | 15 | 69 | 2 | 24019535 | |
| Pubmed | A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. | 4.01e-04 | 15 | 69 | 2 | 20457914 | |
| Pubmed | 4.20e-04 | 488 | 69 | 6 | 31324722 | ||
| Pubmed | 4.56e-04 | 75 | 69 | 3 | 31527668 | ||
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 4.57e-04 | 16 | 69 | 2 | 12399393 | |
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 33060561 | ||
| Pubmed | Loss of PiT-1 results in abnormal endocytosis in the yolk sac visceral endoderm. | 5.18e-04 | 17 | 69 | 2 | 25138534 | |
| Pubmed | Location of transient ectodermal progenitor potential in mouse development. | 5.18e-04 | 17 | 69 | 2 | 24131634 | |
| Pubmed | 5.81e-04 | 18 | 69 | 2 | 30410068 | ||
| Pubmed | 6.49e-04 | 19 | 69 | 2 | 16787915 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 6.83e-04 | 1489 | 69 | 10 | 28611215 | |
| Pubmed | 7.20e-04 | 20 | 69 | 2 | 21689717 | ||
| Pubmed | 7.38e-04 | 204 | 69 | 4 | 25659154 | ||
| Pubmed | Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. | 7.95e-04 | 21 | 69 | 2 | 12202484 | |
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 33372189 | ||
| Pubmed | Novel interaction partners of Bardet-Biedl syndrome proteins. | 7.95e-04 | 21 | 69 | 2 | 18000879 | |
| Pubmed | 8.07e-04 | 209 | 69 | 4 | 36779422 | ||
| Pubmed | Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling. | 8.73e-04 | 22 | 69 | 2 | 26811477 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 8.94e-04 | 564 | 69 | 6 | 21565611 | |
| Pubmed | 9.64e-04 | 1285 | 69 | 9 | 35914814 | ||
| Pubmed | 9.93e-04 | 221 | 69 | 4 | 31796584 | ||
| Pubmed | 1.01e-03 | 1293 | 69 | 9 | 15342556 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.05e-03 | 100 | 69 | 3 | 25807483 | |
| Pubmed | 1.06e-03 | 225 | 69 | 4 | 12168954 | ||
| Pubmed | 1.13e-03 | 25 | 69 | 2 | 16887829 | ||
| Pubmed | 1.14e-03 | 591 | 69 | 6 | 15231748 | ||
| Pubmed | 1.15e-03 | 103 | 69 | 3 | 10574462 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.19e-03 | 232 | 69 | 4 | 25515538 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.25e-03 | 235 | 69 | 4 | 28378594 | |
| Pubmed | 1.28e-03 | 107 | 69 | 3 | 32989256 | ||
| Pubmed | 1.32e-03 | 27 | 69 | 2 | 20301537 | ||
| Interaction | MTNR1B interactions | 3.57e-07 | 135 | 68 | 7 | int:MTNR1B | |
| Interaction | USP12 interactions | 3.09e-06 | 67 | 68 | 5 | int:USP12 | |
| Interaction | DES interactions | 1.55e-05 | 158 | 68 | 6 | int:DES | |
| Interaction | SYNE3 interactions | 1.76e-05 | 444 | 68 | 9 | int:SYNE3 | |
| Interaction | CTNNA1 interactions | 2.14e-05 | 347 | 68 | 8 | int:CTNNA1 | |
| Interaction | KRT24 interactions | 3.30e-05 | 54 | 68 | 4 | int:KRT24 | |
| Interaction | PHTF1 interactions | 4.02e-05 | 20 | 68 | 3 | int:PHTF1 | |
| Interaction | CSRP1 interactions | 6.87e-05 | 65 | 68 | 4 | int:CSRP1 | |
| Interaction | VIM interactions | KRT2 KRT6B LMNB1 KRT6C IFT74 CNTRL ACTN1 APP FLOT1 COPS5 KIF20B | 7.30e-05 | 804 | 68 | 11 | int:VIM |
| Cytoband | 12q13.13 | 1.39e-04 | 67 | 68 | 3 | 12q13.13 | |
| Cytoband | 12q21.2 | 4.04e-04 | 20 | 68 | 2 | 12q21.2 | |
| Cytoband | 15q21.3 | 1.25e-03 | 35 | 68 | 2 | 15q21.3 | |
| GeneFamily | Keratins, type II | 3.78e-05 | 27 | 44 | 3 | 609 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 5.60e-03 | 46 | 44 | 2 | 622 | |
| GeneFamily | Ubiquitin specific peptidases | 8.20e-03 | 56 | 44 | 2 | 366 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIPK3 KMT2C RIPOR2 GVINP1 MTUS1 DTNA TTC14 USP12 MACF1 USP46 APP MINDY2 EPAS1 | 2.12e-07 | 854 | 67 | 13 | M1533 |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 7.74e-07 | 199 | 67 | 7 | M9850 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 TAOK3 LMNB1 SIPA1L1 SYNE2 ID1 USP12 MACF1 FNBP1L APP GINS1 KIF20B | 1.57e-06 | 856 | 67 | 12 | M4500 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIPK3 KMT2C RIPOR2 MTUS1 DTNA TTC14 USP12 MACF1 USP46 APP MINDY2 EPAS1 | 2.29e-06 | 888 | 67 | 12 | MM1018 |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 1.21e-05 | 199 | 67 | 6 | M316 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 1.52e-05 | 313 | 67 | 7 | M39128 | |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | 2.94e-05 | 233 | 67 | 6 | M39036 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 4.44e-05 | 152 | 67 | 5 | M39243 | |
| Coexpression | GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN | 6.19e-05 | 163 | 67 | 5 | M6722 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_UP | 9.63e-05 | 179 | 67 | 5 | M2959 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.17e-04 | 432 | 67 | 7 | MM419 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.40e-04 | 194 | 67 | 5 | M2081 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 1.44e-04 | 195 | 67 | 5 | M13736 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN | 1.51e-04 | 197 | 67 | 5 | M8726 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 1.58e-04 | 199 | 67 | 5 | M3070 | |
| Coexpression | GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP | 1.62e-04 | 200 | 67 | 5 | M8099 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 1.62e-04 | 200 | 67 | 5 | M7020 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_DN | 1.62e-04 | 200 | 67 | 5 | M5456 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.62e-04 | 200 | 67 | 5 | M8500 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 1.62e-04 | 200 | 67 | 5 | M9205 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP | 1.71e-04 | 42 | 67 | 3 | M41209 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.99e-04 | 209 | 67 | 5 | MM1058 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 3.28e-05 | 394 | 67 | 8 | GSM777030_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.50e-05 | 339 | 67 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | RIPOR2 IFT74 DTNA NEXMIF CNTRL SYNE2 E2F7 MACF1 GOLM1 FNBP1L SGO1 KIF20B | 1.06e-04 | 1060 | 67 | 12 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.19e-04 | 152 | 67 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.44e-04 | 84 | 67 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-07 | 176 | 67 | 6 | a3f27b5d7edf2d396c085efbe35305cfa0afa565 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-07 | 197 | 67 | 6 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.54e-07 | 199 | 67 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.54e-07 | 199 | 67 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.70e-07 | 200 | 67 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.70e-07 | 200 | 67 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.70e-07 | 200 | 67 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.70e-07 | 200 | 67 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.70e-07 | 200 | 67 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.70e-07 | 200 | 67 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.70e-07 | 200 | 67 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.70e-07 | 200 | 67 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.45e-06 | 161 | 67 | 5 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.59e-06 | 162 | 67 | 5 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.59e-06 | 162 | 67 | 5 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-06 | 168 | 67 | 5 | c0ff30e2c47005514131a0866cf10a1c228128fc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-06 | 174 | 67 | 5 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-06 | 174 | 67 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-06 | 174 | 67 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-06 | 175 | 67 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.87e-06 | 176 | 67 | 5 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.87e-06 | 176 | 67 | 5 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-06 | 176 | 67 | 5 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.06e-06 | 177 | 67 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 177 | 67 | 5 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.06e-06 | 177 | 67 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 177 | 67 | 5 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 177 | 67 | 5 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 7.06e-06 | 177 | 67 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.06e-06 | 177 | 67 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.06e-06 | 177 | 67 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-06 | 180 | 67 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-06 | 180 | 67 | 5 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.66e-06 | 180 | 67 | 5 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 181 | 67 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.87e-06 | 181 | 67 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-06 | 183 | 67 | 5 | 52af3c943116073c8ddd207b664342960b88929b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.30e-06 | 183 | 67 | 5 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-06 | 184 | 67 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.52e-06 | 184 | 67 | 5 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-06 | 184 | 67 | 5 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-06 | 184 | 67 | 5 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 8.52e-06 | 184 | 67 | 5 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-06 | 185 | 67 | 5 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-06 | 185 | 67 | 5 | 03df43e9c2ce4ec24ffed8e4e2993f94ba951c8b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.75e-06 | 185 | 67 | 5 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-06 | 185 | 67 | 5 | dbdbd6593cd98550238519746bb45fbf0617550b | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 8.75e-06 | 185 | 67 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-06 | 185 | 67 | 5 | de2c24719946d5a37a982d816776cea7f3984c49 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.98e-06 | 186 | 67 | 5 | 422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 186 | 67 | 5 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.98e-06 | 186 | 67 | 5 | 65da0666a10a59f8cc379589860a2e98fe487754 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.98e-06 | 186 | 67 | 5 | dc84fef1ca2f5d5d818b76a3321559e87d1c4a4d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-06 | 187 | 67 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-06 | 187 | 67 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-06 | 187 | 67 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 9.70e-06 | 189 | 67 | 5 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.70e-06 | 189 | 67 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.95e-06 | 190 | 67 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.95e-06 | 190 | 67 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.95e-06 | 190 | 67 | 5 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 191 | 67 | 5 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 191 | 67 | 5 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 191 | 67 | 5 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.02e-05 | 191 | 67 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 192 | 67 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.05e-05 | 192 | 67 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 192 | 67 | 5 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 192 | 67 | 5 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 192 | 67 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-05 | 193 | 67 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.07e-05 | 193 | 67 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | PND14-Endothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 194 | 67 | 5 | cee89d4340738f09d07a159cd6aeee4300776988 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 194 | 67 | 5 | 6115c20ffe414378508f3879e67815b6062341a7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 194 | 67 | 5 | 32962060d80f3edffbe9f0ecad3000c3a9817865 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 194 | 67 | 5 | 6317e9cdf96eb020f84d50bf41f803db5c9c04a0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 194 | 67 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 194 | 67 | 5 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | facs-Heart-LA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 194 | 67 | 5 | 33cc4f1d716cb71d54cdedbe9bbdc0d7b17c4777 | |
| ToppCell | PND28-Endothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 194 | 67 | 5 | b592c713204db7ae2f34a54f2d03d13834593c57 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 194 | 67 | 5 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 195 | 67 | 5 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 195 | 67 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.13e-05 | 195 | 67 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 195 | 67 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 195 | 67 | 5 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 195 | 67 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 195 | 67 | 5 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 195 | 67 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 196 | 67 | 5 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.16e-05 | 196 | 67 | 5 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 196 | 67 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 196 | 67 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 196 | 67 | 5 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 196 | 67 | 5 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-05 | 197 | 67 | 5 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 197 | 67 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| Drug | mant-GTP | 3.36e-07 | 50 | 66 | 5 | CID000128647 | |
| Drug | AC1L9LMC | 4.28e-06 | 83 | 66 | 5 | CID000448113 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.03e-05 | 171 | 66 | 6 | 7535_DN | |
| Drug | dithranol | 1.84e-05 | 18 | 66 | 3 | CID000002202 | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.17e-05 | 195 | 66 | 6 | 3543_UP | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.17e-05 | 195 | 66 | 6 | 5004_DN | |
| Drug | Dioxybenzone [131-53-3]; Down 200; 16.4uM; HL60; HT_HG-U133A | 2.23e-05 | 196 | 66 | 6 | 3101_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.29e-05 | 197 | 66 | 6 | 5697_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 5298_DN | |
| Drug | 5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA | 2.36e-05 | 198 | 66 | 6 | 908_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.36e-05 | 198 | 66 | 6 | 4351_DN | |
| Drug | altizide | 4.95e-05 | 4 | 66 | 2 | CID000002122 | |
| Drug | plakin | 9.50e-05 | 82 | 66 | 4 | CID000018752 | |
| Drug | SC-791 | 1.23e-04 | 6 | 66 | 2 | CID010291510 | |
| Drug | fenoxaprop | 1.72e-04 | 7 | 66 | 2 | CID000086134 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.72e-04 | 179 | 66 | 5 | 4248_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A | 2.16e-04 | 188 | 66 | 5 | 1150_UP | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | NWD2 LMNB1 DTNA CNTRL SYNE2 E2F7 KDR FNBP1L APP SGO1 GINS1 KIF20B STAR | 2.17e-04 | 1441 | 66 | 13 | ctd:C009828 |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A | 2.27e-04 | 190 | 66 | 5 | 2189_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.27e-04 | 190 | 66 | 5 | 3966_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.38e-04 | 192 | 66 | 5 | 1266_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.38e-04 | 192 | 66 | 5 | 4268_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; HL60; HG-U133A | 2.44e-04 | 193 | 66 | 5 | 1417_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.44e-04 | 193 | 66 | 5 | 2332_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 194 | 66 | 5 | 5696_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.50e-04 | 194 | 66 | 5 | 1073_UP | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.50e-04 | 194 | 66 | 5 | 5418_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.50e-04 | 194 | 66 | 5 | 1001_UP | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; PC3; HT_HG-U133A | 2.50e-04 | 194 | 66 | 5 | 5854_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A | 2.50e-04 | 194 | 66 | 5 | 1947_DN | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 3453_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 7288_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 4956_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 7312_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 4148_DN | |
| Drug | Methacholine chloride [62-51-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 3452_DN | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; HL60; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 3085_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 2.62e-04 | 196 | 66 | 5 | 7314_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 5541_UP | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 5874_UP | |
| Drug | Vitexin [3681-93-4]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 4588_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 3456_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 6018_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; HL60; HG-U133A | 2.69e-04 | 197 | 66 | 5 | 2022_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 7138_UP | |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 66 | 5 | 6279_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 2369_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 7299_DN | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 7359_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 2724_DN | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 2774_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 5424_UP | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; PC3; HG-U133A | 2.75e-04 | 198 | 66 | 5 | 1908_DN | |
| Drug | STOCK1N-35696; Down 200; 15uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 6564_DN | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 2425_DN | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.75e-04 | 198 | 66 | 5 | 7303_DN | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 6188_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 6355_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HG-U133A | 2.81e-04 | 199 | 66 | 5 | 1918_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 3520_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.81e-04 | 199 | 66 | 5 | 959_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A | 2.81e-04 | 199 | 66 | 5 | 1933_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A | 2.81e-04 | 199 | 66 | 5 | 1945_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A | 2.81e-04 | 199 | 66 | 5 | 5836_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 5601_UP | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; PC3; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 5043_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; HL60; HT_HG-U133A | 2.88e-04 | 200 | 66 | 5 | 1281_UP | |
| Disease | PR interval | 1.08e-04 | 495 | 65 | 7 | EFO_0004462 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.11e-04 | 12 | 65 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | sphingomyelin 14:0 measurement | 6.36e-04 | 17 | 65 | 2 | EFO_0010390 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 6.39e-04 | 76 | 65 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | electrocardiography | 1.10e-03 | 530 | 65 | 6 | EFO_0004327 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.12e-03 | 206 | 65 | 4 | C0152013 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANNMQEAQSIDEIYK | 16 | Q92905 | |
| AEADQQMDNLYLKAL | 81 | Q99814 | |
| VEIADENNMLLDYQD | 56 | Q7Z7A1 | |
| EQQLDIMNKQYQQLE | 561 | Q7Z7A1 | |
| LAVNQENEQLMEDYE | 266 | P12814 | |
| NEYNALNEAKQMIAV | 311 | Q9BRK5 | |
| LQKEQNYSDDVLANM | 566 | P05067 | |
| FLLDEMQTAQNKYQE | 721 | Q7Z2Y8 | |
| DLLEERNKELMNEYN | 596 | A2A2Z9 | |
| NDYEQNMKLLQTKYD | 471 | Q8N8E3 | |
| YMEEKDDEILQQNNE | 206 | Q96M95 | |
| LNMEKLENEYLDQAN | 1081 | Q9P1Z9 | |
| KDLDLNYMTQTNDQN | 426 | Q8TAM1 | |
| AQKLYLQDDNDLREM | 741 | Q9ULI1 | |
| QELQNLLDKYMKNSD | 546 | Q8HWS3 | |
| LLDEQQVNVLLYDMN | 56 | P41134 | |
| NMQDLVEDLKNKYED | 241 | P48668 | |
| ETQQLLQMQQKYLEE | 3186 | Q8NEZ4 | |
| LQAKIINNNYMDTDN | 831 | Q2M2H8 | |
| AEKYKMQLQEQFDNL | 1026 | Q9ULD2 | |
| NSELNNMQDLVEDYK | 251 | P35908 | |
| DQMQQQLNDYEQLLD | 351 | P20700 | |
| SALEKNMENYLQEQK | 451 | O14782 | |
| NMENYLQEQKERLEE | 456 | O14782 | |
| QLYQEAAQLDMLLEK | 346 | O75955 | |
| NMQDLVEDLKNKYED | 241 | P04259 | |
| ESIKDYEQANLNMAN | 251 | Q96Q89 | |
| EMLEQNLYDFLKQNK | 276 | Q9H422 | |
| LNLLEMEYSGDLKQN | 531 | Q86UA1 | |
| MEYSGDLKQNEENIL | 536 | Q86UA1 | |
| EKLEDAMQAAVQYQD | 6106 | Q9UPN3 | |
| QEYRDEQDLNMKLVQ | 301 | Q96M91 | |
| QMRAKYLENLAQENE | 1916 | Q4G0P3 | |
| NDYNMLKAQNDRETQ | 171 | Q96LB3 | |
| YEEQMAYLQQKELDL | 231 | Q96AV8 | |
| NQYADMLNKKFLDQA | 1001 | Q14185 | |
| MADENKNEYAAQLQN | 181 | Q5T0N5 | |
| QEMDKLKEQYDAELQ | 776 | Q0VF96 | |
| EALELMNQNLDIYEQ | 81 | P43251 | |
| DYQLKAVVQMENLQD | 831 | Q9Y4F3 | |
| NQAFNEDNLKFILMD | 61 | Q9Y2Q5 | |
| RQLENELQMEEYLKQ | 716 | Q9Y4J8 | |
| QNSLEYMDQNDDRLK | 276 | Q14CZ8 | |
| MQLNEQLKAVYEFQD | 1256 | A4D0S4 | |
| NQQKLRGEDDYNMDE | 341 | Q8NBJ4 | |
| QQQQAEYEDLMGQKD | 371 | Q4V328 | |
| EYEDLMGQKDDLNSQ | 376 | Q4V328 | |
| NLEHLYLQNNEIEKM | 301 | Q99983 | |
| KGQQDQIDQDYLMAL | 506 | Q8NBR6 | |
| QNQYKKQMLDDIPED | 206 | Q8NHS9 | |
| NAEENDKLYKVLQNM | 3126 | Q8WXH0 | |
| EILNELYQQKEMALQ | 1521 | Q5JRA6 | |
| ENMKYGEQLLSDQLL | 191 | Q5QGS0 | |
| QMAYENLNDKDQELG | 491 | P13521 | |
| NYQDNNKMLVLALEN | 56 | Q5FBB7 | |
| TEQLMKLDEQGLNYQ | 596 | O43166 | |
| QLQQEMELLNAYQSK | 801 | Q9H2K8 | |
| LLALQMNEEQYQKDG | 496 | Q9NWF9 | |
| QYKEFQDLNQEVMNL | 621 | Q9Y4F9 | |
| MYDAGQAKQELLQQE | 691 | Q96JN2 | |
| ELMQQYLKEQESYDN | 41 | Q86X95 | |
| IKYSMDDQLNQLFNL | 531 | P63136 | |
| QELAYLQQGEEAMQK | 71 | P49675 | |
| ELLDQSYKQDEQLAM | 731 | Q9HCF6 | |
| GELLNQVQMAKLYQD | 36 | O43280 | |
| RKENELFDNYMQQDA | 111 | O75317 | |
| AMNEYNKALEIDKQN | 326 | Q96N46 | |
| LRKENDLFDNYMQQD | 106 | P62068 | |
| IMELKNASLQDQGDY | 626 | P35968 | |
| IKYSMDDQLNQLFNL | 536 | Q9WJR5 | |
| MKALYEQNQSDVNEA | 36 | Q14691 | |
| DKAQINLYQDVMLEN | 26 | Q96NJ3 | |
| LYEEEMEELSNLNKN | 541 | Q496Y0 |